225 related articles for article (PubMed ID: 26101425)
1. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
2. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
3. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
4. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG
J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?
Szymanska S; Grajkowska W; Sobieszczanska-Malek M; Zielinski T; Pyzlak M; Pronicki M
Pol J Pathol; 2016; 67(3):216-220. PubMed ID: 28155969
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
[TBL] [Abstract][Full Text] [Related]
8. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
[TBL] [Abstract][Full Text] [Related]
9. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
Cai Q; Moore SA; Hendricks AR; Torrealba JR
Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
[TBL] [Abstract][Full Text] [Related]
11. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
12. Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
Frea S; Iacovino C; Botta M; De Filippi I; Mazzucco G; Pidello S; Biolè C; Bergerone S; Boffini M; Praticò Barbato L; Morello M; Rinaldi M; Gaita F
Clin Transplant; 2016 Oct; 30(10):1314-1323. PubMed ID: 27490635
[TBL] [Abstract][Full Text] [Related]
13. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
Mohamedali B; Pyle J; Bhat G
Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
Fedson SE; Daniel SS; Husain AN
J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
[TBL] [Abstract][Full Text] [Related]
15. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.
Gupta S; Mitchell JD; Lavingia B; Ewing GE; Feliciano MN; Kaiser PA; Ring WS; Stastny P; Patel PC; Markham DW; Mammen PP; Dimaio JM; Drazner MH
J Heart Lung Transplant; 2009 Aug; 28(8):776-80. PubMed ID: 19632572
[TBL] [Abstract][Full Text] [Related]
16. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
17. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
[TBL] [Abstract][Full Text] [Related]
18. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
[TBL] [Abstract][Full Text] [Related]
19. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation.
Kfoury AG; Renlund DG; Snow GL; Stehlik J; Folsom JW; Fisher PW; Reid BB; Clayson SE; Gilbert EM; Everitt MD; Bader FM; Singhal AK; Hammond ME
J Heart Lung Transplant; 2009 Jan; 28(1):51-7. PubMed ID: 19134531
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
